Hypocalcemia with Immune Checkpoint Inhibitors: The Disparity among Various Reports

Immune-related adverse events affecting parathyroid function are rarely reported with immune checkpoint inhibitors (ICPIs). Activating calcium-sensing receptor antibodies causing autoimmune hypoparathyroidism with nivolumab was recently reported. KEYNOTE-189 and CHECKMATE-067 trials reported a 21–29...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Endocrinol
Main Authors: Nalluru, Swarna Sri, Piranavan, Paramarajan, Ning, Ying, Ackula, Haritha, Siddiqui, Ahmad D., Trivedi, Nitin
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294349/
https://ncbi.nlm.nih.gov/pubmed/32587615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7459268
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares